Peak Frameworks

SEPTEMBER 19, 2023

In the world of finance and corporate responsibility, two terms frequently arise: "stakeholder" and "shareholder." A shareholder is an individual or entity that owns shares or stock in a corporation. What is a Shareholder? By virtue of their ownership, they possess a direct financial interest in the company's success.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

M&A Leadership Council

AUGUST 15, 2022

A sell-off, which is by far the most common type of divestiture (and the type usually referred to as such), is the sale of one or more company units to another company – for example, when BF Goodrich Corporation sold its JcAIR Test Systems business to Aeroflex Incorporated in 2005. What is a spin-off? . What is a split-up?

Mergers and Acquisitions 52

Mergers and Acquisitions IPO M&A Initial Public Offering 52

M&A Leadership Council

JUNE 12, 2023

Mark Herndon (MH): IT M&A leaders often talk about adding more strategic value throughout the M&A lifecycle for both corporate development and the enterprise integration lead. MH: Anna, how would you advise a company’s CISO to engage corporate development early in the strategic development and target selection process?

IT 52

IT M&A Securities Insurance 52

M&A Leadership Council

SEPTEMBER 9, 2021

MH: IT M&A leaders often talk about adding more strategic value throughout the M&A lifecycle for both corporate development and the enterprise integration lead. MH: Anna, how would you advise a company’s CISO to engage corporate development early in the strategic development and target selection process?

IT 52

IT M&A Securities Insurance 52

Mergers and Inquisitions

NOVEMBER 1, 2023

In terms of mobility , you could easily join a healthcare investment banking team , move to a portfolio company in a corporate development role, or potentially even move into venture capital if you’ve had some life sciences exposure. What about when the IPO market is shut down and exits look uncertain? in biology. If you have an M.D.

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

FEBRUARY 15, 2017

Dealmakers appear much more optimistic in the first quarter of 2017 than at this same time last year, in part because of greater optimism about the IPO market and the potential for favorable corporate tax and other regulatory changes. We expect this trend to continue, with mid-market and smaller deals driving the deal count in 2017.

M&A 40

M&A IPO Pharmaceutical Valuation 40